The field of aging and dementia is focusing on the characterization of the earliest stages of
cognitive impairment. Recent research has identified a transitional state between the …

Risk for late-onset Alzheimer’s disease (LOAD), the most prevalent dementia, is partially
driven by genetics. To identify LOAD risk loci, we performed a large genome-wide association …

Background Overstimulation of the N-methyl-D-aspartate (NMDA) receptor by glutamate is
implicated in neurodegenerative disorders. Accordingly, we investigated memantine, an …

Background Alzheimer's disease is characterized by amyloid-beta plaques, neurofibrillary
tangles, gliosis, and neuronal loss. Solanezumab, a humanized monoclonal antibody, …

Background Mild cognitive impairment is a transitional state between the cognitive changes
of normal aging and early Alzheimer's disease. Methods In a double-blind study, we …

Background Alzheimer's disease is characterized by the presence of cortical amyloid-beta (Aβ)
protein plaques, which result from the sequential action of β-secretase and γ-secretase …

Background Donepezil hydrochloride (Aricept) is a selective acetylcholinesterase inhibitor
developed for the treatment of Alzheimer disease. This phase 3 study was 1 of 2 pivotal trials …

ContextSeveral reports from small clinical trials have suggested that estrogen replacement
therapy may be useful for the treatment of Alzheimer disease (AD) in women.ObjectiveTo …

Background Mild cognitive impairment (MCI) represents a transitional state between the
cognitive changes of normal aging and very early dementia and is becoming increasingly …

We identified rare coding variants associated with Alzheimer's disease in a three-stage case–control
study of 85,133 subjects. In stage 1, we genotyped 34,174 samples using a whole-…